from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2398c/cysW

LFCtreatmentdescriptionclass of inhibitor

-0.318

Amikacinug/mL Amikacintranslation

-0.899

Cap5-10ug/mL Capreomycintranslation

-0.283

Rox10-50 ug/mL Roxithromycintranslation

0.066

SM2-5 ug/mL Streptomycintranslation

0.240

Tet5-10 ug/mL Tetracyclinetranslation

0.803

Rif0.2-5ug/mL Rifampicintranscription

0.068

Rifp0.1-0.5ug/mL Rifapentinetranscription

3.423

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.459

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.313

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.631

Clofazimine10-13 ug/mL Clofaziminerespiration

0.238

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.201

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.905

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.819

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.120

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.304

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.152

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.133

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

2.384

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.384

KCN5-20 ug/mL Potassium cyaniderespiration

0.038

NaN30.2-2 mM Sodium aziderespiration

0.091

Nigericin50 uM Nigericinrespiration

-0.118

TRC10-150 ug/mL Triclosanrespiration

-0.609

TRZ10-25 ug/mL Thioridazinerespiration

-0.630

Valinomycin0.5-10 uM Valinomycinrespiration

-1.877

ZnSO42 mM ZnSO4respiration

2.365

menadione6-10 ug/mL Menadionerespiration

-0.248

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.080

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.084

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.382

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.739

NRP_1Non-replicating persistence stage 1dosRassociated

-0.624

Amp0.2mg/mL AmpicillincellWall

-0.128

Cephalexin20-100 ug/mL CephalexincellWall

-0.611

Cerulenin0.32-5 ug/mL CerulenincellWall

0.286

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.117

EMB10-20 ug/mL EthambutolcellWall

-0.380

Eta12-40 ug/mL EthionamidecellWall

-0.248

INH0.2-0.4 ug/mL IsoniazidcellWall

0.015

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.184

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.052

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.630

BZA0.12 mg/mL BenzamidearomaticAmides

-0.448

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.467

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.175

H2O24 mM hydrogen peroxideDNAdamaging

-1.054

Levo10 ug/mL LevofloxacinDNAdamaging

0.200

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.384

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.089

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.782

UVUV-irradiationDNAdamaging

4.850

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.271

Antimycin12.5-50 ug/mL Antimycin A?

0.540

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.318

PA_110-50 ug/mL Antitubercular compound PA-1?

0.123

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.375

PA8240.2-2 ug/mL PA-824?

0.012

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.233

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.228

Verapamil50 uM Verapamil?

0.222

mercaptoethanol2 mM 2-Mercaptoethanol?

0.052

methoxatin10-20 ug/mL Methoxatin?